Parexel International is an American provider of biopharmaceutical services. It conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process. It is the second largest clinical research organization in the world and has helped develop approximately 95% of the 200 top-selling biopharmaceuticals on the market today. The company publishes the annual Parexel R&D Statistical Sourcebook, operates the Parexel-Academy, and councils all of the top 50 biopharmaceutical and top 30 biotechnology companies.
Attributes | Values |
---|
rdf:type
| |
rdfs:label
| - Parexel (de)
- Parexel (eo)
- Parexel (fr)
- Parexel (en)
- Parexel (sv)
|
rdfs:comment
| - Parexel estas kompanio kun sidejo en Waltham (Masaĉuseco), kie ĝi proponas servojn por la medicina, farmakologia industrio. En marto de 2006 Parexel okazigis eksperimenton per kontraŭinflama medikamento TGN1412, evoluigita por trakti reŭmatismajn, leŭkemiajn, sklerozajn malsanojn. Dum la testo 6 volontuloj grave malsaniĝis en Londono. Esploroj montris, ke tiuj problemoj ne estis antaŭvideblaj. (eo)
- Parexel est une entreprise américaine de sous-traitance pharmaceutique dans les essais cliniques et des fonctions associés. Elle est basée à Waltham dans le Massachusetts. Elle possède environ 18 000 employés. (fr)
- Parexel är ett biomedicinskt tjänsteföretag baserat i Waltham, Massachusetts. I mars 2006 gick ett Parexel-hanterat test av substansen TGN1412 fel, och resultatet blev kraftig inflammation och multipel organsvikt hos sex friska frivilliga försökspersoner i London. Preparatet hade tidigare testats i laboratorier och på djur. (sv)
- Parexel International ist einer der weltweit führenden Dienstleister für biopharmazeutische Forschung. Es führt im Auftrag von Kunden aus dem Pharmabereich klinische Studien durch und begleitet und beschleunigt dadurch die Arzneimittelzulassung. PAREXEL ist das weltweit zweitgrößte Auftragsforschungsinstitut und war an der Entwicklung von etwa 95 % der 200 heute auf dem Markt meistverkauften Biopharmazeutika beteiligt. Das Unternehmen veröffentlicht das jährlich erscheinende PAREXEL R&D Statistical Sourcebook, betreibt die PAREXEL-Academy, und berät sowohl alle Top 50 biopharmazeutischen als auch Top 30 biotechnologischen Unternehmen. (de)
- Parexel International is an American provider of biopharmaceutical services. It conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process. It is the second largest clinical research organization in the world and has helped develop approximately 95% of the 200 top-selling biopharmaceuticals on the market today. The company publishes the annual Parexel R&D Statistical Sourcebook, operates the Parexel-Academy, and councils all of the top 50 biopharmaceutical and top 30 biotechnology companies. (en)
|
foaf:name
| - Parexel International (en)
|
foaf:homepage
| |
name
| - Parexel International (en)
|
foaf:depiction
| |
location
| |
dcterms:subject
| |
Wikipage page ID
| |
Wikipage revision ID
| |
Link from a Wikipage to another Wikipage
| - Cambridge, Massachusetts
- Privately held company
- Queensland
- San Diego
- Schering-Plough
- Berlin, Germany
- Biostatistics
- Birmingham, UK
- Contract research organizations
- Horsham, Pennsylvania
- Pharmaceutical
- Pharmacology
- Pharmacovigilance
- Reston, VA
- Rheumatoid arthritis
- In vitro
- Bloemfontein, South Africa
- Biotechnology companies of the United States
- Medicines and Healthcare products Regulatory Agency
- George, South Africa
- Goldman Sachs
- Multiple sclerosis
- Contract research organization
- Leukaemia
- London
- Luton
- Clinical trial
- Harrow (UK Parliament constituency)
- Pharmaceutical industry
- Australia
- Brisbane
- Washington, D.C.
- Whitehall Township, Lehigh County, Pennsylvania
- Companies based in Massachusetts
- Durham, North Carolina
- FDA
- Bankruptcy
- Brian Deer
- Northwick Park Hospital
- Nottingham
- Paris
- Companies formerly listed on the Nasdaq
- Istanbul
- Crawley (UK Parliament constituency)
- First-in-man study
- Channel 4
- King of Prussia, Pennsylvania
- Biotechnology
- Taiwan
- Excerpta Medica Database
- Newton, Massachusetts
- Orange, California
- Orléans
- Calyx AI
- Phases of clinical research
- Randomization
- Multiple organ failure
- TGN1412
- Bangalore, India
- TeGenero
- Lucerne, Switzerland
- Covance Inc.
- Poitiers, France
- GlaxoWellcome Inc.
- Reed Elsevier plc
- Clinical research organization
- Anti-inflammatory drug
|
Link from a Wikipage to an external page
| |